Materialise NV (MTLS)

NMS – Real vaqt narxi. Valyuta: USD

7.07

+0.18 (2.61%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

7.19

+0.12 (1.70%)

Bozordan keyin: Jun 26, 2026, 4:49 PM EDT

15.06.2026

All You Need to Know About Materialise (MTLS) Rating Upgrade to Buy

Materialise (MTLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

29.05.2026

Best Stocks to Buy Before June 2026: 3 Breakout Stocks Ready to Surge

MTLS, LXFR and ARKO emerged as June breakout stock picks after strong gains and screening tied to price momentum and resistance levels.

12.05.2026

Are Investors Undervaluing Materialise (MTLS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

08.05.2026

Materialise Q1 Earnings Call Highlights

Materialise NASDAQ: MTLS reported first-quarter 2026 revenue of EUR 66.3 million, which Chief Financial Officer Koen Berges said was stable year-over-year despite “significant foreign exchange headwinds,” primarily tied to a weaker U.S. dollar. Gross profit rose to EUR 37.9 million and gross margin expanded to 57.2%, helping drive improved profitability and positive free cash flow during the period.

07.05.2026

Materialise NV (MTLS) Q1 2026 Earnings Call Transcript

07.05.2026

Materialise Reports First Quarter 2026 Results

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the first quarter ended March 31, 2026. Additionally, Materialise announced the transfer of its eyewear business to the eyewear management team. Highlights – First Quarter 2026 Total revenue was stable at 66,276 kEUR for the first quarter of 2026 compared.

29.04.2026

Materialise: The Medical Segment Alone Makes This A Buy

Materialise receives a 'Buy' rating, driven by robust growth in its medical segment despite weakness in software and manufacturing. MTLS's medical segment boasts a 4-year CAGR of 16%, with management guiding for continued strong growth through FY2026. The company maintains a fortress balance sheet with €71m net cash and trades at a significant discount to sector peers on EV/Sales and EV/EBITDA.

Videolar

No Data

There is no data to display

Press-relizlar

07.05.2026

Materialise NV (MTLS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Materialise NV (MTLS)

All You Need to Know About Materialise (MTLS) Rating Upgrade to Buy

Best Stocks to Buy Before June 2026: 3 Breakout Stocks Ready to Surge

Are Investors Undervaluing Materialise (MTLS) Right Now?

Materialise Q1 Earnings Call Highlights

Materialise NV (MTLS) Q1 2026 Earnings Call Transcript

Materialise Reports First Quarter 2026 Results

Materialise: The Medical Segment Alone Makes This A Buy

Videolar

No Data

Press-relizlar

Materialise Reports First Quarter 2026 Results

All You Need to Know About Materialise (MTLS) Rating Upgrade to Buy

Best Stocks to Buy Before June 2026: 3 Breakout Stocks Ready to Surge

Are Investors Undervaluing Materialise (MTLS) Right Now?

Materialise Q1 Earnings Call Highlights

Materialise NV (MTLS) Q1 2026 Earnings Call Transcript

Materialise Reports First Quarter 2026 Results

Materialise: The Medical Segment Alone Makes This A Buy

Videolar

No Data

Press-relizlar

Materialise Reports First Quarter 2026 Results

Materialise to Transfer RapidFit Business to Its Management Team

Materialise Reports Fourth Quarter and Full Year 2025 Results

Materialise Successfully Launched on Euronext Brussels – Information on the Total Number of Voting Rights and Shares

Search stocks

Materialise NV (MTLS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Materialise NV (MTLS)

All You Need to Know About Materialise (MTLS) Rating Upgrade to Buy

Best Stocks to Buy Before June 2026: 3 Breakout Stocks Ready to Surge

Are Investors Undervaluing Materialise (MTLS) Right Now?

Materialise Q1 Earnings Call Highlights

Materialise NV (MTLS) Q1 2026 Earnings Call Transcript

Materialise Reports First Quarter 2026 Results

Materialise: The Medical Segment Alone Makes This A Buy

Videolar

No Data

Press-relizlar

Materialise Reports First Quarter 2026 Results

All You Need to Know About Materialise (MTLS) Rating Upgrade to Buy

Best Stocks to Buy Before June 2026: 3 Breakout Stocks Ready to Surge

Are Investors Undervaluing Materialise (MTLS) Right Now?

Materialise Q1 Earnings Call Highlights

Materialise NV (MTLS) Q1 2026 Earnings Call Transcript

Materialise Reports First Quarter 2026 Results

Materialise: The Medical Segment Alone Makes This A Buy

Videolar

No Data

Press-relizlar

Materialise Reports First Quarter 2026 Results

Materialise to Transfer RapidFit Business to Its Management Team

Materialise Reports Fourth Quarter and Full Year 2025 Results

Materialise Successfully Launched on Euronext Brussels – Information on the Total Number of Voting Rights and Shares